Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Novartis launches storytelling app for neuroendocrine tumor community

Novartis launched its Galaxies of Hope app, a unique digital experience created to support the neuroendocrine tumor community.

Read More »

Mining online discussions for deeper customer insight

This is a case study by TechEmergence, an artificial intelligence market research and media platform.

Read More »

Rockpointe and AudioEducate launch first-ever accredited CME program on Amazon’s Echo

The CME provider Rockpointe launched the first CME-certified course ever offered on Amazon Echo through the AudioEducate platform with joint providers Potomac Center for Medical Education (PCME) and the Academy of Physicians in Clinical Research (APCR).

Read More »

Highmark inks outcomes contract with second pharma brand

Continuing its efforts to address high prescription drug costs, insurer Highmark entered into a new outcomes-based contract with Boehringer Ingelheim for Jardiance (empagliflozin), an oral medicine indicated to lower blood sugar in adults with type 2 diabetes, and also to reduce the risk of cardiovascular death in adults with type 2 diabetes who have known cardiovascular disease.

Read More »

Health Outcomes: Facts & Figures

Physicians and health plan executives agree that healthcare has made little progress toward value-based care since last year, according to a survey by Quest Diagnostics.

Read More »

Outlook good: A peek into the healthcare agency crystal ball

Let’s have a peek in the crystal ball 10 years into the future. What will agencies look like then? What will the marketplace look like?

Read More »

New CEO and chief scientific officer for OrphoMed

Gary M. Phillips, M.D., has been made president and CEO of OrphoMed Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics.

Read More »

Triumvira expands management team

Triumvira Immunologics appointed Sabine Chlosta, M.D., Ph.D., as chief medical officer and Jon Irvin as VP of finance.

Read More »

People on the Move: Biotechnology/Biopharmaceutical

James (Jim) Robinson is named president and CEO of Alkermes Inc. Robinson joined Alkermes from Astellas US LLC, where he served as president, Americas Operations with responsibility for the company’s operations in North and South America. Alkermes is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) […]

Read More »

People on the Move: Specialty Pharma

Jacob Chacko, M.D., is now CEO of ORIC Pharmaceuticals. Rich Heyman, Ph.D., who served as the interim CEO, became chairman of the ORIC board of directors. The former chairman, Peter Svennilson, remains on the board.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom